Opioid disorder treatment
Despite the medical profession’s growing acceptance of the need for medications for addiction treatment for people suffering from opioid use disorder, a study conducted by clinician-scientists at OHSU found that insurance rules increasingly limited the use of buprenorphine among Medicare beneficiaries between 2007 and 2018. (OHSU/Kristyna Wentz-Graff)
OHSU Accolades: Awards, honors and appointments March 20
Recordatorio en la semana nacional de la prevención de intoxicaciones: Las intoxicaciones se pueden prevenir
National Poison Prevention Week reminder: Poisonings are preventable
Listos para la residencia: estudiantes de Medicina celebran la próxima etapa en sus carreras
Residency ready: M.D. students celebrate the next stage of their careers
OHSU names new director of Oregon National Primate Research Center
Gary Westbrook, M.D., (2019)
Gary Westbrook, M.D., senior scientist in the Vollum Institute. (OHSU/Kristyna Wentz-Graff)
NMDA receptor
A 3D printed model of the part of the NMDA receptor that is attacked by a brain disease, chronicled in Susannah Cahalan's autobiography "Brain on Fire." Scientists at the OHSU Vollum Institute have developed an animal model to study the disease. (OHSU)
NMDA receptor encephalitis
Gary Westbrook, M.D., talks about the new animal model identified to study NMDA receptor encephalitis. (OHSU)